Crystal structure of the major diabetes autoantigen insulinoma-associated protein 2 reveals distinctive immune epitopes

Diabetes

Volumn 56, Issue 1, 2007, Pages 41-48

  Seung, Jun Kim ^a   Dae, Gwin Jeong ^a   Sook, Kyung Jeong ^a   Yoon, Tae Seong ^a   Seong, Eon Ryu ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE; INSULINOMA ASSOCIATED PROTEIN 2; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; BETA SHEET; CRYSTAL STRUCTURE; DIABETES MELLITUS; ENZYME ACTIVITY; MUTAGENESIS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; T LYMPHOCYTE;

AMINO ACID SEQUENCE; AUTOANTIGENS; CRYSTALLOGRAPHY, X-RAY; DIABETES MELLITUS, TYPE 1; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; KINETICS; MEMBRANE PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33847014189     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0237     Document Type: Article

References (48)

1. Palmer JP, Asplin CM, Clemons P: Insulin autoantibodies in insulin-dependent diabetes before insulin treatment. Science 222:1337-1339, 1983
2. Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229, 2001
3. Leslie RDG, Atkinson MA, Notkins AL: Autoantigens IA2 and GAD in type 1 (insulin dependent) diabetes. Diabetologia 42:3-14, 1999
4. Nishino M, Ikegami H, Kawaguchi Y, Fujisawa T, Kawabata Y, Shintani M, Ono M, Horiki M, Kawasaki E, Ogihara T: Polymorphism in gene for islet autoantigen IA-2, and type 1 diabetes in Japanese subjects. Hum Immunol 62:518-522, 2001
5. Notkins AL, Lernmark A: Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Imvest 108:1247-1252, 2001
6. Solimena M, Dirkx R Jr, Hermel JM, Pleasic-Williams S, Shapiro JA, Caron L, Rabin DU: ICA 512, an autoantigen of type 1 diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 15:2102-2114, 1996
7. Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E: Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J Immunol 157:2707-2711, 1996
8. Zhang B, Lan MS, Notkins AL: Autoantibodies to IA-2 in IDDM: location of major antigenic determinants. Diabetes 46:40-43, 1997
9. Xie H, Zhang B, Matsumoto Y, Li Q, Notkins AL, Lan MS: Autoantibodies to IA-2 and IA-2β in insulin-dependent diabetes mellitus recognize conformational epitopes: location of the 37- and 40-kDa fragments determined. J Immunol 159:3662-3667, 1997
10. Honeyman MC, Stone NL, Harrison LC: T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med 4:231-239, 1998
11. Saeki K, Zhu M, Kubosaki A, Xie J, Lan MS, Notkins AL: Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion. Diabetes 51:1842-1850, 2002
12. Cai T, Fukushige T, Notkins AL, Krause M: Insulinoma-associated protein IA-2, a vesicle transmembrane protein, genetically interacts with UNC-31/CAPS and affects neurosecretion in Caenorhabditis elegans. J Neurosci 24:3115-3124, 2004
13. Ort T, Voronov S, Guo J, Zawalich K, Froehner SC, Zawalich W, Solimena M: Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion. EMBO J 20:4013-4023, 2001
14. Gross S, Blanchetot C, Schepens J, Albet S, Lammers R, den Hertog J, Hendriks W: Multimerization of the protein-tyrosine phosphatase (PTP)-like insulin-dependent diabetes mellitus autoantigens IA-2 and IA-2beta with receptor PTPs (RPTPs): inhibition of RPTPalpha enzymatic activity. J Biol Chem 277:48139-48145, 2002
15. Lu J, Notkins AL, Lan MS: Isolation, sequence and expression of a novel mouse-brain cDNA, mIA-2, and its relatedness to members of the protein tyrosine phosphatase family. Biochem Biophys Res Comm 204:930-936, 1994
16. Drake PG, Peters GH, Andersen HS, Hendriks W, Møller NPH: A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2b). Biochem J 373:393-401, 2003
17. Magistrelli G, Toma S, Isacchi A: Substitution of two variant residues in the protein tyrosine phosphatase-like PTP35/IA-2 sequence reconstitutes catalytic activity. Biochem Biophys Res Comm 227:581-588, 1996
18. Wishart MJ, Dixon JE: Gathering STYX: phosphatase-like form predicts functions from unique protein-interaction domains. Trends Biochem Sci 23:301-306, 1998
19. Kolm-Litty V, Berlo S, Bonifacio E, Bearzatto M, Engel AM, Christie M, Ziegler AG, Wild T, Endl J: Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen. J Immunol 165:4676-4684, 2000
20. Leslie AG: Integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr D55:1696-1702, 1999
21. Collaborative Computational Project, Number 4: The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr D50:760-763, 1994
22. Nam HJ, Poy F, Krueger NX, Saito H, Frederick CA: Crystal structure of the tandem phosphatase domains of RPTP LAR. Cell 97:449-457, 1999
23. Kissinger CR, Gehlhaar DK, Fogel DB: Rapid automated molecular replacement by evolutionary search. Acta Crystallogr D Biol Crystallogr D55:484-491, 1999
24. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL: Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr D54:905-921, 1998
25. Jones TA, Zou JY, Cowan SW, Kjeldgaard M: Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr D Biol Crystallogr A47:110-119, 1991
26. Laskowski RA, MacArthur MW, Moss DS, Thornton JM: PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283-291, 1993
27. Barford D, Flint AJ, Tonks NK: Crystal structure of human protein tyrosine phosphatase 1B. Science 263:1397-1404, 1994
28. Sonnenburg ED, Bilwes A, Hunter T, Noel JP: The structure of the membrane distal phosphatase domain of RPTPα reveals interdomain flexibility and an SH2 domain interaction region. Biochemistry 42:7904-7914, 2003
29. Salmeen A, Andersen JN, Myers MP, Tonks NK, Barford D: Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol Cell 6:1401-1412, 2000
30. Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY: Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. Proc Natl Acad Sci U S A 94:13420-13425, 1997
31. Jia Z, Barford D, Flint AJ, Tonks NK: Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science 268:1754-1758, 1995
32. Buis P, Zhang YL, Keng YF, Wu Y, Zhang ZY, den Hertog J: Restoration of potent protein-tyrosine phosphatase activity into the membrane-distal domain of receptor protein-tyrosine phosphatase alpha. Biochemistry 38:914-922, 1998
33. Lee JO, Yang H, Georgescu MM, Cristofano AD, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP: Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association. Cell 99:323-334, 1999
34. Bearzatto M, Lampasona V, Belloni C, Bonifacio E: Fine mapping of diabetes-associated IA-2 specific autoantibodies. J Autoimmun 21:377-382, 2003
35. Dromey JA, Weenink SM, Peters GH, Endl J, Tighe PJ, Todd I, Christie MR: Mapping of epitopes for autoantibodies to the type 1 diabetes autoantigen IA-2 by peptide phage display and molecular modeling: overlap of antibody and T cell determinants. J Immunol 172:4084-4090, 2004
36. Watts C, Antoniou A, Manoury B, Hewitt EW, Mckay LM, Grayson L, Fairweather NF, Emsley P, Isaacs N, Simitsek PD: Modulation by epitope-specific antibodies of class II MHC-restricted presentation of the tetanus toxin antigen. Immunol Rev 164:11-16, 1998
37. Quaratino S, Ruf J, Osman M, Guo J, McLachlan S, Rapoport B, Londei M: Human autoantibodies modulate the T cell epitope repertoire but fail to unmask a pathogenic cryptic epitope. J Immunol 174:557-563, 2005
38. Wong FS, Wen L, Tang M, Ramanathan M, Visintin I, Daugherty J, Hannum LG, Janeway CA Jr, Shlomchik MJ: Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 53:2581-2587, 2004
39. Christen U, von Herrath MG: Initiation of autoimmunity. Curr Opin Immunol 16:759-767, 2004
40. Peakman M, Stevens EJ, Lohmann T, Narendran P, Dromey J, Alexander A, Tomlinson AJ, Trucco M, Gorga JC, Chicz RM: Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J Clin Invest 104:1449-1457, 1999
41. Hawkes CJ, Schloot NC, Marks J, Willemen SJ, Drijfhout JW, Mayer EK, Christie MR, Roep BO: T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 49:356-366, 2000
42. Moreno R, Jiang L, Moehle K, Zurbriggen R, Gluck R, Robinson JA, Pluschke G: Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design. Chembiochem 2:838-843, 2001
43. Berezov A, Chen J, Liu Q, Zhang HT, Greene MI, Murali R: Disabling receptor ensembles with rationally designed interface peptidomimetics. J Biol Chem 277:28330-28339, 2002
44. Plagemann PGW: Peptide ELISA for measuring antibodies to N-protein of porcine reproductive and respiratory syndrome virus. J Virol Methods 134:99-118, 2006
45. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acid Res 22:4673-4680, 1994
46. Barton GJ: ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng 6:37-40, 1993
47. Nicholls A, Sharp KA, Honig B: Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281-296, 1991
48. Ananieva-Jordanova R, Evans M, Nakamatsu T, Premawardhana LD, Sanders J, Powell M, Chen S, McGrath V, Belton C, Arnold C, Baker S, Betterle C, Zanchetta R, Smith BR, Furmaniak J: Isolation and characterization of a human monoclonal autoantibody to the islet cell autoantigen IA-2. J Autoimmun 24:337-345, 2005